Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2023		55,822
Beginning balance at Dec. 31, 2023	$ 1,188,954	$ 56	$ (290,319)	$ 1,122,292	$ 370,357	$ (13,432)
Balance at beginning of period (in shares) at Dec. 31, 2023			(10,283)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(15,676)				(15,676)
Other comprehensive income (loss)	(1,399)					(1,399)
Share-based compensation	9,381			9,381
Issuance of common stock under employee stock plans (in shares)		385
Issuance of common stock under employee stock plans	8,042			8,042
Tax payments related to restricted stock units	(705)			(705)
Balance at end of period (in shares) at Mar. 31, 2024		56,207
Ending balance at Mar. 31, 2024	$ 1,188,597	$ 56	$ (290,319)	1,139,010	354,681	(14,831)
Balance at end of period (in shares) at Mar. 31, 2024			(10,283)
Balance at beginning of period (in shares) at Dec. 31, 2024	46,382	56,665
Beginning balance at Dec. 31, 2024	$ 1,243,313	$ 57	$ (290,319)	1,167,882	382,888	(17,195)
Balance at beginning of period (in shares) at Dec. 31, 2024	(10,283)		(10,283)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (7,023)				(7,023)
Other comprehensive income (loss)	3,388					3,388
Share-based compensation	11,547			11,547
Issuance of common stock under employee stock plans (in shares)		462
Issuance of common stock under employee stock plans	8,266			8,266
Tax payments related to restricted stock units	$ (2,391)			(2,391)
Balance at end of period (in shares) at Mar. 31, 2025	46,844	57,127
Ending balance at Mar. 31, 2025	$ 1,257,100	$ 57	$ (290,319)	$ 1,185,304	$ 375,865	$ (13,807)
Balance at end of period (in shares) at Mar. 31, 2025	(10,283)		(10,283)